Enhancing Care in Hematologic Malignancies through Targeted Therapies (IMAGE)

American Society of Hematology

Enhancing Care in Hematologic Malignancies through Targeted Therapies

Caption

Four studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta highlight the multiple ways in which novel targeted cancer therapies are now being deployed to improve outcomes and quality of life for patients with rare, advanced, or difficult-to-treat blood malignancies.

Credit

American Society of Hematology

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.